We are live on ! Find out more
ARLZ

Aralez Pharmaceuticals Inc.
ARLZ

Delisted

ARLZ was delisted on the 20th of August, 2018.

Back to rankings

83 hedge funds and large institutions have $128M invested in Aralez Pharmaceuticals Inc. in 2016 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 29 increasing their positions, 19 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

53% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 19

8% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 13

0% more funds holding

Funds holding: 83 → 83 (0)

9% less capital invested

Capital invested by funds: $140M → $128M (-$11.9M)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

28% less call options, than puts

Call options by funds: $666K | Put options by funds: $920K

Holders
83
Holders Change
–
Holders Change %
0%
% of All Funds
2.07%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
14
Increased
29
Reduced
19
Closed
13
Calls
$666K
Puts
$920K
Net Calls
-$254K
Net Calls Change
+$876K

Top Buyers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
+$4.27M
2
AC
Armistice Capital
New York
+$3.49M
3
BC
Broadfin Capital
New York
+$1.83M
4
Norges Bank
Norges Bank
Norway
+$600K
5
Morgan Stanley
Morgan Stanley
New York
+$548K

Top Sellers

Rank Fund Capital Flow
1
VOAM
Vertex One Asset Management
British Columbia, Canada
-$1.57M
2
KAM
Kavi Asset Management
New York
-$1.52M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$1.34M
4
Millennium Management
Millennium Management
New York
-$1.08M
5
AA
Ancora Advisors
Ohio
-$634K
Name Holding Trade Value Shares
Change 		Change in
Stake
California Public Employees Retirement System
26
California Public Employees Retirement System
California
$467K – – –
AG
27
Advisor Group
Arizona
$463K -$48.3K -10,181 -9%
GPC
28
Glacier Peak Capital
Washington
$452K +$268K +56,400 +123%
KPF
29
K2 Principal Fund
Ontario, Canada
$435K +$380K +80,045 +432%
AA
30
Ancora Advisors
Ohio
$426K -$634K -133,634 -58%
IAM
31
Integre Asset Management
New York
$361K +$93.6K +19,715 +32%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$358K -$9.51K -2,004 -2%
FMA
33
FNY Managed Accounts
New York
$326K +$71.1K +14,983 +25%
Macquarie Group
34
Macquarie Group
Australia
$307K -$381K -80,333 -54%
O
35
OrbiMed
New York
$301K – – –
BAS
36
Brown Advisory Securities
Maryland
$291K +$313K +66,000 New
Northern Trust
37
Northern Trust
Illinois
$286K +$7.29K +1,535 +2%
SCA
38
Salient Capital Advisors
Texas
$265K +$47.5K +10,000 +20%
CS
39
Credit Suisse
Switzerland
$251K +$211K +44,514 +360%
Citadel Advisors
40
Citadel Advisors
Florida
$221K +$22.6K +4,755 +10%
NL
41
NWAM LLC
Washington
$208K – – –
JGC
42
J. Goldman & Co
New York
$198K +$214K +45,000 New
ProShare Advisors
43
ProShare Advisors
Maryland
$191K +$205K +43,224 New
AG
44
Algert Global
California
$187K +$201K +42,407 New
D.E. Shaw & Co
45
D.E. Shaw & Co
New York
$166K -$1.34M -283,185 -88%
DMK
46
David M. Knott
$166K – – –
CWM
47
Circle Wealth Management
New Jersey
$140K +$151K +31,852 New
DS
48
DRW Securities
Illinois
$136K -$260K -54,699 -64%
Geode Capital Management
49
Geode Capital Management
Massachusetts
$131K +$3.29K +692 +2%
Bank of Montreal
50
Bank of Montreal
Ontario, Canada
$125K -$62 -13 -0.1%
1
2
3 4

ARLZ Hedge Fund Activity: Q4 2016 in Review

83 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in Aralez Pharmaceuticals Inc. (ARLZ) for Q4 2016, worth a combined $128M — down 8.5% from $140M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new ARLZ positions and 13 closed out — a net gain of 1 holder — while 29 added to existing stakes and 19 trimmed.

The largest buyer was BlackRock Fund Advisors, opening a new position worth an estimated $4.27M. The largest seller was Vertex One Asset Management, exiting entirely with an estimated $1.57M sold.

  • 83 institutional investors held Aralez Pharmaceuticals Inc. (ARLZ) as of Q4 2016, unchanged from Q3 2016.
  • Funds reported $128M of Aralez Pharmaceuticals Inc. stock for Q4 2016, down 8.5% quarter-over-quarter.
  • 14 funds opened new Aralez Pharmaceuticals Inc. positions in Q4 2016 and 13 closed out, a net change of +1 holder.
  • The largest Aralez Pharmaceuticals Inc. buyer in Q4 2016 was BlackRock Fund Advisors, an estimated $4.27M added.
  • The largest Aralez Pharmaceuticals Inc. seller in Q4 2016 was Vertex One Asset Management, an estimated $1.57M sold.

Based on aggregated 13F filings for Q4 2016.